drugset / Trial / NCT06284902
Bioavailability Study of Fexofenadine HCl New Formulation Tablet
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to assess the relative bioavailability of a new galenic form of fexofenadine HCl new formulation tablet (test drug) taken with or without water compared to fexofenadine HCl film-coated tablets (reference form) taken with water under fasting conditions.
Timeline
- Start
- 2024-02-23
- Primary completion
- 2024-05-08
- Completion
- 2024-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexofenadine | Unknown | — | — |
Indications
No indication recorded.